DK1212336T3 - Fremgangsmåde til fremstilling af sfæriske agglomerater af telithromycin og deres anvendelse ved fremstilling af farmaceutiske former - Google Patents

Fremgangsmåde til fremstilling af sfæriske agglomerater af telithromycin og deres anvendelse ved fremstilling af farmaceutiske former

Info

Publication number
DK1212336T3
DK1212336T3 DK00958756T DK00958756T DK1212336T3 DK 1212336 T3 DK1212336 T3 DK 1212336T3 DK 00958756 T DK00958756 T DK 00958756T DK 00958756 T DK00958756 T DK 00958756T DK 1212336 T3 DK1212336 T3 DK 1212336T3
Authority
DK
Denmark
Prior art keywords
preparation
telithromycin
pharmaceutical forms
spherical agglomerates
agglomerates
Prior art date
Application number
DK00958756T
Other languages
Danish (da)
English (en)
Inventor
Jean-Yves Godard
Valerie Rognon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1212336(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1212336T3 publication Critical patent/DK1212336T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK00958756T 1999-08-26 2000-08-28 Fremgangsmåde til fremstilling af sfæriske agglomerater af telithromycin og deres anvendelse ved fremstilling af farmaceutiske former DK1212336T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
PCT/FR2000/002393 WO2001014393A2 (fr) 1999-08-26 2000-08-28 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (1)

Publication Number Publication Date
DK1212336T3 true DK1212336T3 (da) 2004-03-15

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00958756T DK1212336T3 (da) 1999-08-26 2000-08-28 Fremgangsmåde til fremstilling af sfæriske agglomerater af telithromycin og deres anvendelse ved fremstilling af farmaceutiske former

Country Status (34)

Country Link
US (1) US6825218B1 (de)
EP (1) EP1212336B1 (de)
JP (1) JP4871467B2 (de)
KR (1) KR100718222B1 (de)
CN (1) CN1183151C (de)
AR (1) AR025398A1 (de)
AT (1) ATE255590T1 (de)
AU (1) AU774385B2 (de)
BR (1) BR0013569B1 (de)
CA (1) CA2382497C (de)
CO (1) CO5190666A1 (de)
CZ (1) CZ2002594A3 (de)
DE (1) DE60006976T2 (de)
DK (1) DK1212336T3 (de)
EA (1) EA005080B1 (de)
ES (1) ES2209970T3 (de)
FR (1) FR2797875B1 (de)
HK (1) HK1049167B (de)
HR (1) HRP20020167B1 (de)
HU (1) HU229075B1 (de)
IL (2) IL148128A0 (de)
ME (2) MEP20108A (de)
MX (1) MXPA02001988A (de)
NO (1) NO322622B1 (de)
PL (1) PL204100B1 (de)
PT (1) PT1212336E (de)
RS (1) RS50433B (de)
SI (1) SI1212336T1 (de)
SK (1) SK287588B6 (de)
TR (1) TR200200506T2 (de)
TW (1) TWI272949B (de)
UA (1) UA73523C2 (de)
WO (1) WO2001014393A2 (de)
ZA (1) ZA200201599B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
EP1524966B1 (de) * 2002-07-19 2009-11-25 Aventis Pharma S.A. Geschmacksmaskierte orale zubereitung von telithromycin
DK1610878T3 (da) * 2003-02-21 2014-12-01 Univ Bath Fremgangsmåde til fremstilling af partikler
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (de) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Herstellung von feinen Materialien
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
ES2209970T3 (es) 2004-07-01
EP1212336B1 (de) 2003-12-03
BR0013569A (pt) 2002-05-14
FR2797875B1 (fr) 2001-10-19
TWI272949B (en) 2007-02-11
PL353137A1 (en) 2003-10-20
TR200200506T2 (tr) 2002-08-21
HK1049167B (zh) 2005-08-19
NO322622B1 (no) 2006-11-06
ZA200201599B (en) 2003-04-30
AU7018100A (en) 2001-03-19
HUP0202842A3 (en) 2003-03-28
UA73523C2 (uk) 2005-08-15
HU229075B1 (hu) 2013-07-29
JP4871467B2 (ja) 2012-02-08
WO2001014393A3 (fr) 2001-06-21
NO20020926D0 (no) 2002-02-26
PL204100B1 (pl) 2009-12-31
MEP20108A (en) 2010-06-10
AR025398A1 (es) 2002-11-27
CA2382497A1 (fr) 2001-03-01
AU774385B2 (en) 2004-06-24
CN1183151C (zh) 2005-01-05
HK1049167A1 (en) 2003-05-02
CZ2002594A3 (cs) 2002-09-11
MXPA02001988A (es) 2002-08-20
US6825218B1 (en) 2004-11-30
EP1212336A2 (de) 2002-06-12
FR2797875A1 (fr) 2001-03-02
RS50433B (sr) 2009-12-31
IL148128A (en) 2006-10-31
KR100718222B1 (ko) 2007-05-15
YU13202A (sh) 2004-09-03
CN1371386A (zh) 2002-09-25
SI1212336T1 (en) 2004-04-30
BR0013569B1 (pt) 2014-02-25
PT1212336E (pt) 2004-04-30
HRP20020167B1 (en) 2006-06-30
KR20020033771A (ko) 2002-05-07
EA200200294A1 (ru) 2002-08-29
SK2532002A3 (en) 2002-09-10
HUP0202842A2 (hu) 2003-01-28
JP2003507484A (ja) 2003-02-25
HRP20020167A2 (en) 2003-06-30
ME00112B (me) 2010-10-10
NO20020926L (no) 2002-02-26
IL148128A0 (en) 2002-09-12
WO2001014393A2 (fr) 2001-03-01
CO5190666A1 (es) 2002-08-29
DE60006976D1 (de) 2004-01-15
EA005080B1 (ru) 2004-10-28
SK287588B6 (sk) 2011-03-04
CA2382497C (fr) 2011-06-28
ATE255590T1 (de) 2003-12-15
DE60006976T2 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
NO20022680L (no) Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser
NO20015278L (no) 6-alkenyl-, 6-alkynyl- og 6-epoksy-epotilonderivater, fremgangsmåte for deres fremstilling og deres anvendelse ifarmasöytiske preparater
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
DK1345895T3 (da) Hidtil ukendt diphenylazetidioner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse til behandling af lipidstofskifteforstyrrelser
DK1083889T3 (da) Tetrahydronaphthalenforbindelser og deres anvendelse til behandling af neurodegenerative sygdomme
NO20015045L (no) Diaminotiazoler og deres anvendelse til inhibering av proteinkinaser
NO994014D0 (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
DK1183029T3 (da) Farmaceutisk præparat indeholdende diamorfin og vitamin E og dets anvendelse til behandling af opiatmisbrug
NO20010277D0 (no) Benzocykloheptener, fremgangsmåte for fremstilling derav, farmasöytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20024176L (no) Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
NO20041994L (no) Nye beta-fenyl-alfa-oksysubstituerte propion derivater: Fremgangsmate for deres fremstilling og deres anvendelse ved fremstilling av farmasoytisk riktige forbindelser
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DK1212336T3 (da) Fremgangsmåde til fremstilling af sfæriske agglomerater af telithromycin og deres anvendelse ved fremstilling af farmaceutiske former
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
DK1381382T3 (da) Fremgangsmåder og præparater til behandling af öjensygdomme
NO20001905D0 (no) Forbindelser og deres anvendelse i farmasøytiske eller kosmetiske preparater
NO20020031D0 (no) Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20043295L (no) Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser
DK1353912T3 (da) 2-Arylimino-2,3-dihydrothiazolderivater, fremgangsmåderne til deres fremstilling og deres terapeutiske anvendelse
DK1239862T3 (da) Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft
NO20030547L (no) Azabicykliske derivater og deres terapeutiske anvendelse